UCB's Global Corporate Website
Welcome to UCB in the United States


Find U.S. news and updates from UCB, a global biopharmaceutical company focused on creating value for people living with severe diseases, such as epilepsy, Parkinson’s disease, psoriasis, osteoporosis, myasthenia gravis,  rheumatoid arthritis, psoriatic arthritis, non-radiographic axial spondyloarthritis, and more. 

Spotlight Story

No results



UCB U.S. News

Disease Spotlight: Thymidine Kinase 2 Deficiency (TK2d)

Read More

UCB PharmD Second-Year Fellows Share Reflections and Advice

Read More

Announcing the 2023 UCB Family Epilepsy Scholarship Winners

Read More

Twitter Feed

For More Information